Two new 13-hydroxylated milbemycin metabolites from the genetically engineered strain AVE-H39.

J Asian Nat Prod Res

Life Science and Biotechnology Research Center, School of Life Science, Northeast Agricultural University, Harbin 150030, China.

Published: September 2021

Two new milbemycin metabolites, 13-hydroxymilbemycin () and 26-methyl-13-hydroxymilbemycin (), were isolated from the fermentation broth of a genetically engineered strain AVE-H39. Their structures were determined by the comprehensive spectroscopic data, including 1 D, 2 D NMR, MS spectral analysis and the comparison with data from the literature. Compounds and not only exhibited potent acaricidal activities against , but also had nematocidal activity against .

Download full-text PDF

Source
http://dx.doi.org/10.1080/10286020.2020.1803294DOI Listing

Publication Analysis

Top Keywords

milbemycin metabolites
8
genetically engineered
8
engineered strain
8
strain ave-h39
8
13-hydroxylated milbemycin
4
metabolites genetically
4
ave-h39 milbemycin
4
metabolites 13-hydroxymilbemycin
4
13-hydroxymilbemycin 26-methyl-13-hydroxymilbemycin
4
26-methyl-13-hydroxymilbemycin isolated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!